By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Clinical Studies Confirm Perimenopause Brain Fog Is Real Biology, Not Psychology

Clinical Studies Confirm Perimenopause Brain Fog Is Real Biology, Not Psychology

GMJ
Last updated: 26/06/2026 02:26
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Brain scan images showing cognitive changes during perimenopause transition
New clinical research quantifies cognitive decline during perimenopause, showing measurable impacts on memory and executive function. Studies reveal 42% of perimenopausal women experience significant cognitive difficulties affecting daily functioning. — Photo by Anna Shvets on Pexels (Pexels License)
SHARE
1 min read|131 words

New clinical evidence validates what millions of women experience during perimenopause: measurable cognitive decline affecting memory, concentration, and executive function. Research published in peer-reviewed journals demonstrates that brain fog during the menopausal transition stems from measurable biological changes, not psychological factors as previously assumed. Standardized neuropsychological testing shows significant decreases in verbal memory, working memory, and processing speed compared to premenopausal baselines, with deficits peaking during late perimenopause when hormone fluctuations are most pronounced. Neuroimaging studies reveal reduced brain connectivity in regions critical for memory and executive function during periods of low estrogen. These findings have substantial implications for clinical practice, workplace accommodations, and treatment strategies. Both hormonal and non-hormonal interventions show promise in managing symptoms and preserving cognitive function during this transitional period. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Clinical Evidence Links Perimenopause Brain Fog to Measurable Cognitive Decline →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations…

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

The UK's Cover of Vaccination Evaluated Rapidly (COVER) programme reports sustained high…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Community health workers in discussion during mental health training session

Mental Health Crisis in Low-Income Countries: Kenya Study Reveals Protective Organizational Factors

By
Prof. Giorgi Pkhakadze
21/07/2026
Medical professional discussing opioid treatment medication policy

Evidence-Based Opioid Treatments Face Federal Scrutiny Amid Political Divide

By
Prof. Giorgi Pkhakadze
02/07/2026
Comparison of fish oil oxidation levels and safety testing standards across commercial supplement products

Fish Oil Quality Crisis: Half of Supplements Fail Safety Tests, Yet Short-Term Studies Show No Harm

By
Prof. Giorgi Pkhakadze
01/08/2026
Global HealthPolicy & Systems

WHO Declares Ebola Outbreak Public Health Emergency as Virus Crosses DRC-Uganda Border

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up